Here’s what you need to know.
1. The DC Bead LUMI is a radiopaque embolic drug-eluting bead that can have doxorubicin loaded into it to treat hepatocellular carcinoma or irinotecan for treating malignant colorectal cancer.
2. The DC Bead LUMI is the next iteration of the DC Bead which BTG says is the market leading drug-eluting embolic bead.
3. The new model allows for real-time confirmation of the devices location throughout embolization.
4. Sunnybrook Health Sciences Centre in Toronto, Canada, performed the first procedure with the new device.
More articles on gastroenterology/endoscopy:
AGA releases animated video for GERD education: 3 highlights
Invendo receives CE Mark for sterile, single-use endoscope: 5 things you need to know
Allergan settles with Zydus and Cadila over Delzicol: 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
